Oncohematology in the Era of Immunotherapies: The Key Role of the Human Leukocyte Antigen (HLA) Complex

Immunotherapy has transformed the therapeutic landscape of onco-hematology, evolving from historical allogeneic hematopoietic stem cell transplantation (HSCT) to modern chimeric antigen receptor (CAR) T/NK cell therapies, bispecific antibodies, and immune checkpoint inhibitors. Central to this immunological cross-talk is the Human Leukocyte Antigen (HLA) system, which governs self/non-self-discrimination, alloreactivity, and tumor immune evasion across both classical allografts and novel adoptive cellular platforms. Facing hematological malignancies, ranging from acute leukemias and multiple myeloma to chronic leukemias and lymphomas, clinicians must overcome tumor immune escape while managing treatment-related toxicities and Graft-versus-Host Disease (GvHD). Advances in high-throughput molecular biology techniques, notably Next-Generation Sequencing (NGS) and long-read sequencing, have become indispensable for high-resolution HLA matching, minimal residual disease (MRD) monitoring, and chimerism analysis. Furthermore, gene-editing strategies (e.g., CRISPR/Cas9) targeting TRAC, B2M, and CIITA, alongside HLA-E engineering and induced pluripotent stem cell (iPSC) technology, are driving the development of universal “off-the-shelf” effector platforms that bypass classic HLA barriers. In this review, we provide a conceptual synthesis of immunotherapeutic paradigms in onco-hematology, highlighting the pivotal role of HLA biology and molecular diagnostics in shaping next-generation personalized cellular therapies.

Authors

Institutions

Publication Details

Journal
Cells
Published
2026-11-19
DOI
https://doi.org/10.3390/cells15222111
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Oncohematology in the Era of Immunotherapies: The Key Role of the Human Leukocyte Antigen (HLA) Complex

Pascal Pedini, Régis T. Costello, Christophe Picard, Jean A. Gabert
Cells
Hematopoietic Stem Cell Transplantation
article

Oncohematology in the Era of Immunotherapies: The Key Role of the Human Leukocyte Antigen (HLA) Complex

Pascal Pedini, Régis T. Costello, Christophe Picard, Jean A. Gabert
article en

Abstract

Immunotherapy has transformed the therapeutic landscape of onco-hematology, evolving from historical allogeneic hematopoietic stem cell transplantation (HSCT) to modern chimeric antigen receptor (CAR) T/NK cell therapies, bispecific antibodies, and immune checkpoint inhibitors. Central to this immunological cross-talk is the Human Leukocyte Antigen (HLA) system, which governs self/non-self-discrimination, alloreactivity, and tumor immune evasion across both classical allografts and novel adoptive cellular platforms. Facing hematological malignancies, ranging from acute leukemias and multiple myeloma to chronic leukemias and lymphomas, clinicians must overcome tumor immune escape while managing treatment-related toxicities and Graft-versus-Host Disease (GvHD). Advances in high-throughput molecular biology techniques, notably Next-Generation Sequencing (NGS) and long-read sequencing, have become indispensable for high-resolution HLA matching, minimal residual disease (MRD) monitoring, and chimerism analysis. Furthermore, gene-editing strategies (e.g., CRISPR/Cas9) targeting TRAC, B2M, and CIITA, alongside HLA-E engineering and induced pluripotent stem cell (iPSC) technology, are driving the development of universal “off-the-shelf” effector platforms that bypass classic HLA barriers. In this review, we provide a conceptual synthesis of immunotherapeutic paradigms in onco-hematology, highlighting the pivotal role of HLA biology and molecular diagnostics in shaping next-generation personalized cellular therapies.

CellsVol. 15(22)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Aix-Marseille Université (FR), Hôpital de la Conception (FR), Theories and Approaches of Genomic Complexity (FR), Établissement Français du Sang (FR), Institut de Neurosciences de la Timone (FR), Hôpital de la Timone (FR), Anthropologie Bio-Culturelle, Droit, Éthique & Santé (FR)
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon